部分切除・放射線療法後,エトポシドで寛解となった脊髄退形成性星細胞腫の乳児例
政輝 楠田, 嘉文 河野, 康裕 岡本 et al. · 日本小児血液・がん学会雑誌 · 2018
Cited by 0 works. doi:10.11412/jspho.55.417
Authors
References
- The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial
- Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
- Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
- The treatment of malignant brain tumors in infants and very young children: An update of the Pediatric Oncology Group experience
- Temozolomide in Malignant Gliomas of Childhood: A United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study
- Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma
- Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children
- High‐grade astrocytoma in very young children
- High-grade glioma in children under 5 years of age: A chemotherapy only approach with the BBSFOP protocol
- Phase II study of 21 day schedule oral etoposide in children